Stock News•1 day ago
Moderna and Novavax Stocks Slump as Biotech's Rally Takes a Breather
Moderna and Novavax shares fell as biotech's rally paused, with Moderna and Revolution Medicines awaiting catalysts that could sustain gains.
MarketLens
The FDA Just Killed the Biotech Fast Lane—And Moderna's Stock Is the First Casualty
10 months ago
SHARE THIS ON:
Exclusive Content for Pro Members
Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.
SHARE THIS ON:
Related Articles
Is the FDA Poised to Reshape the Peptide Market
6 months ago
Category
You may also like
Stock News•1 months ago
Moderna Is Up 350% Since Our Recommendation. Here's What to Do Next.
Moderna shares rose 350% since a prior recommendation, driven by AI-accelerated clinical development of therapies. The gain highlights a broader industry transformation toward faster drug development ...
Stock News•2 months ago
The Food and Drug Administration approved Moderna's mRNA flu vaccine, the first of its kind, capping a review that nearly collapsed in February.
Moderna's mRNA flu vaccine won FDA approval, the first of its kind, after a seven-month review that nearly collapsed in February. The decision clears a major regulatory hurdle for the company's pipeli...
Breaking News
View All →Featured Articles
Top Headlines
Stock News•1 hour ago
Greg Abel Made Major Additions to Alphabet and Delta Last Quarter While Berkshire Bought Back $4.4 Billion of Its Own Stock. Is This a Buying Signal Investors Should Watch?
Stock News•3 hours ago
Lightbridge (LTBR) CEO on CEG & GOOGL Nuclear Energy Deal, Global Expansion
Stock News•4 hours ago
Apple's Market Value Grew From $350 Billion to $5 Trillion During Tim Cook's 15 Years as CEO. Here's What That Growth Curve Means for Apple's Next Chapter Under John Ternus.
Stock News•5 hours ago
GOOGL SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Alphabet Investors of Securities Class Action Lawsuit Deadline on November 30, 2026
Stock News•6 hours ago